Agios Pharmaceuticals Inc (NASDAQ:AGIO)

114.43
Data as of Dec 26
 +4.76 / +4.34%
Today’s Change
21.70
Today|||52-Week Range
124.39
+377.79%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$4.2B

Company Description

Agios Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in cellular metabolism to transform the lives of patients with cancer and inborn errors of metabolism, or IEMs, which are a subset of orphan genetic metabolic diseases. The company's products include IDH1 AND IDH2, PKR, II D-2 hydroxyglutaric aciduria, AG-221, AG-120 and AG-348. Agios Pharmaceuticals was founded by Lewis Clayton Cantley, Tak W. Mak and Craig B. Thompson on August 7, 2007 and is headquartered in Cambridge, MA.

Contact Information

Agios Pharmaceuticals, Inc.
38 Sidney Street
Cambridge Massachusetts 02139-4169
P:(617) 649-8600
Investor Relations:
(617) 649-8608

Employees

Shareholders

Individual stakeholders44.50%
Mutual fund holders43.07%
Other institutional13.84%

Top Executives

David Paul SchenkeinPresident, Chief Executive Officer & Director
John Duncan HiggonsChief Operating Officer
Glenn GoddardSenior Vice President-Finance
Shin-San Michael SuSenior Vice President-Research & Development
Scott BillerChief Scientific Officer

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.